ABSTRACT
This systematic review with meta-analysis and meta-regression investigated the effects of individualized exercise interventions consisting with or without combined psychological intervention on pain intensity and disability in patients with chronic non-specific low-back-pain. Databases were searched up to 31 January 2022 and we selected randomized controlled trials involving adults with chronic non-specific low-back-pain being treated with individualized/personalized/stratified exercise interventions with or without psychological treatment compared to any control.
Fifty-eight studies (n = 10084) were included.
At short-term follow-up (12 weeks), low-certainty evidence for pain intensity (SMD -0.28 [95%CI -0.42 to -0.14]) and very low-certainty evidence for disability (−0.17 [-0.31 to -0.02]) indicates effects of individualized versus active exercises, and very low-certainty evidence for pain intensity (−0.40; [-0.58 to -0.22])), but not (low-certainty evidence) for disability (−0.18; [-0.22 to 0.01]) compared to passive controls.
At long-term follow-up (1 year), moderate-certainty evidence for pain intensity (−0.14 [-0.22 to -0.07]) and disability (−0.20 [-0.30 to -0.10]) indicates effects versus passive controls.
Sensitivity analyses indicates that the effects on pain, but not on disability (always short-term and versus active treatments) were robust. Pain reduction caused by individualized exercise treatments in combination with psychological interventions (in particular behavioural-cognitive therapies) (−0.28 [-0.42 to -0.14], low certainty) is of clinical importance.
Certainty of evidence was downgraded mainly due to evidence of risk of bias, publication bias and inconsistency that could not be explained.
Individualized exercise can be recommended from a clinical point of view to treat pain and disability in chronic non-specific low-back-pain. Sub-group analysis suggests a combination of individualized exercise (especially motor-control based treatments) with behavioural therapy interventions to booster effects. Certainty of evidence was moderate for long-term follow-up.
PROSPERO registration CRD42021247331
Competing Interest Statement
JF received honorary for scientific counselling from the German Medical Acupuncture Association. All other authors declare no conflict of interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.